Plasma Soluble Dipeptidyl Peptidase-4: A Possible Mechanism for Identifying and Managing Poststroke Cognitive Impairment

Stroke. 2023 Jan;54(1):122-123. doi: 10.1161/STROKEAHA.122.041522. Epub 2022 Dec 7.

Authors

Nadine E Andrew^{1

2}, Velandai Srikanth^{1

2

3}

Affiliations

¹ Department of Medicine, Peninsula Clinical School, Central Clinical School, Monash University, Frankston, Victoria, Australia (N.E.A., V.S.).
² National Centre for Healthy Ageing, Frankston, Victoria, Australia (N.E.A., V.S.).
³ Department of Medicine & Geriatric Medicine, Frankston Hospital, Peninsula Health, Melbourne, Australia (V.S.).

PMID: 36475463
DOI: 10.1161/STROKEAHA.122.041522

No abstract available

Keywords: dementia; glucose; homeostasis; ischemic stroke; linagliptin.

Publication types

Editorial
Comment

MeSH terms

Cognitive Dysfunction* / diagnosis
Cognitive Dysfunction* / etiology
Diabetes Mellitus, Type 2*
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
Humans
Hypoglycemic Agents
Linagliptin

Substances

Hypoglycemic Agents
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
Linagliptin